专家授课环节亮点纷呈，来自上海华山医院、广西医科大学第一附属医院的专家围绕临床核心难点，结 合真实病例拆解前沿诊疗理念与实操技巧，针对性指导直击痛点。 病例研讨环节，各方观点在不断碰撞中绽放火花。广东三九脑科医院专家分享机器人活检应用、肺癌脑 播散等方面的典型病例，与会者围绕诊断难点、治疗优化等问题深入探讨，形成多项诊疗共识，为同类 病例诊治提供宝贵参考。 本报讯（记者罗颢）12月27日，广西医学会神经病学分会疑难病诊治学组交流会——2025年粤桂疑难脑 病论坛举行。多地医学精英通过"线上+线下"方式交流，为破解疑难脑病诊疗困局注入动能。 论坛承办方代表、广西医大开元埌东医院院长刘震宇表示，本次论坛邀请了广东、广西等地的医疗专家 聚焦颅内病变鉴别、神经病理活检等关键议题，通过鲜活病例分享与深度研讨，传递前沿技术，交流实 战经验，为促进区域诊疗水平的提升开辟新思路。 在新技术突破方面，广西医大开元埌东医院脑病中心主任林涛介绍了两大"利器"：机器人辅助脑病活检 技术创伤小、准确率超95%，可解决"取不准病灶"的难题，大幅缩短确诊周期；脑脊液细胞学精细化检 测技术能让感染性脑血管病等"隐性"脑病显形，显著提升诊疗效 ...

Group 1 - The Jinan Municipal Commission for Discipline Inspection and Supervision is focusing on improving the management of medical consumables to enhance transparency and reduce risks in healthcare [1][3] - The city is implementing a comprehensive approach to address issues such as repeated medical examinations and illegal charges, ensuring that corrective measures are effectively enforced [1][2] - A total of 300 medical examination and testing items have been integrated into a mutual recognition platform across public medical institutions, saving patients approximately 35.6 million yuan in medical expenses [2] Group 2 - The city has established 13 big data screening models to combat common healthcare fraud behaviors, leading to the handling of 142 problem clues and the initiation of 72 cases this year [3][4] - The Jinan Municipal Commission is promoting a real-time dynamic supervision platform for medical consumables across 22 medical institutions, enhancing internal control mechanisms [3][4] - Educational initiatives have reached over 44,000 individuals this year, fostering a culture of integrity and cleanliness within the healthcare sector [4]

医学重点学科是衡量一所医院学科建设水平与核心竞争力的重要标尺，评估验收标准严苛，竞争激烈。 此次通过省级评估验收，不仅代表贵州航天医院呼吸与危重症医学科在临床能力、技术水平、人才建 设、科研创新及区域影响力等方面实力获得官方"认证"，更标志着该科室诊疗水平迈入全省先进行列。 据了解，该科室是贵州省内呼吸疾病诊疗品牌科室。现开放床位350张，设有4个病区、RICU、呼吸介 入诊疗中心、慢病康复治疗中心和呼吸疾病研究中心实验室，在肺癌与肺结节、慢性阻塞性肺疾病、肺 炎、肺结核等呼吸系统疾病的诊疗方面形成了区域特色优势。 12月26日，贵州省卫生健康委员会公布2023年—2024年度立项建设的省级医学重点学科评估验收结果， 贵州航天医院呼吸与危重症医学科顺利通过评估验收，成为贵州省卫生健康委省级医学重点学科。 同时，该科室作为贵州省县级医院微创介入诊疗中心、遵义市呼吸系统疾病临床诊疗中心、遵义市呼吸 内科医疗质量控制中心，积极推动优质医疗资源下沉，与四川、云南、重庆等70余家县（市）级基层医 院建立了"贵州航天医院呼吸与危重症专科联盟"，通过技术帮扶、人才培养等方式，为基层培养了大批 医疗骨干，有力推动了西南地区呼 ...

Group 1 - The Qinghai Provincial Drug Administration has strengthened collaboration with health, medical insurance, and other departments to promote the coordinated development and governance of the "three medicines" [1] - The province has completed the integration of various systems, including medical institution basic information, vaccine planning, adverse reaction monitoring, and drug smart supervision platforms [1] - A total of 150 types of Tibetan and Mongolian medicine pieces and 531 types of Tibetan and Mongolian medical institution preparations have been included in the medical insurance payment scope [1] Group 2 - Continuous reinforcement of drug quality supervision has been emphasized, focusing on key areas, links, and varieties through various special rectification actions [2] - The establishment of a problem ledger and implementation of a closure management system to strengthen corporate responsibility [2] - A comprehensive annual inspection plan for drugs, medical devices, and cosmetics has been developed to enhance the targeting and coverage of inspections [2]

央广网北京12月27日消息（总台记者谭瑱 刘颖超）据中央广播电视总台中国之声《新闻纵横》报道，中国之声大型记录报道《民生样本 年度记录》， 精心选择10个地点，10个领域，从不同角度呈现生活的日新月异。本期推出《智慧医疗，守护患者每一刻》，听前沿技术如何赋能急救与诊疗，感受智慧医 疗背后的温暖守护。 近日，山东济南的一位老人突发心脏骤停。此时，山东大学齐鲁医院派出的急救车正全速疾驰赶往现场。同时，院内也正在进行"隔空救援"。 医护1：拿手机的老师把镜头对准患者。开始对他进行按压，按压的位置在两个乳头中间的位置。 医护2：快点按压、快点按压。我们120车就在路上，很快就到。 医护1：方向朝正下方，你现在有点往前按了。按得再深一点。 这是一次可视急救指导。医院院前急救科的医护人员正通过视频连线指导患者家属，对患者进行心肺复苏。经过家属和医护人员的接力急救，患者到院 后恢复自主循环。 医院院前急救科主治医师张建波告诉中国之声记者，医院打造了5G智能急诊急救系统。依托这一系统，拨打120的呼救人只需点击120急救指挥中心推 送的短信链接，他的手机就会立刻成为能记录现场情况的视频直播终端。 张建波说："我们接到任务之后 ...

www.hczq.com 证券研究报告 | 医药生物 | 2025年12月27日 华创医药投资观点&研究专题周周谈 · 第156期 SMO格局稳固，行业有望开启成长新周期 本周专题联系人：王宏雨 华创医药团队： | 首席分析师 郑辰 | | | 执业编号：S0360520110002 | 邮箱：zhengchen@hcyjs.com | | --- | --- | --- | --- | --- | | 联席首席分析师 | 刘浩 | | 执业编号：S0360520120002 | 邮箱：liuhao@hcyjs.com | | 医疗器械组组长 | | 李婵娟 | 执业编号：S0360520110004 | 邮箱：lichanjuan@hcyjs.com | | 中药和流通组组长 | 高初蕾 | | 执业编号：S0360524070002 | 邮箱：gaochulei@hcyjs.com | | 分析师 王宏雨 | | | 执业编号：S0360523080006 | 邮箱：wanghongyu@hcyjs.com | | 分析师 朱珂琛 | | | 执业编号：S0360524070007 | 邮箱：zhukec ...

Core Insights - The emergence of generative AI marks a shift from digital technology as merely a "connecting tool" to a core component in judgment, decision-making, and action within organizations [3] - Companies now face the critical question of how to effectively integrate AI to create real value rather than merely adopting it as a trend [3][12] Group 1: Industry Transformation - Digital transformation has historically focused on "connection," with a race to establish networks and data integration across various sectors [2] - The introduction of AI challenges traditional notions of efficiency, emphasizing the need for stability, risk control, and long-term certainty in complex systems [5][13] - AI's true value is becoming evident in industries with low penetration and minimal tolerance for error, such as manufacturing and agriculture [6][10] Group 2: AI in Manufacturing - In manufacturing, the example of Jianghuai Zunji Super Factory illustrates how AI can manage increasing complexity and maintain quality standards through digital twin technology and flexible production [8][9] - AI acts as a stabilizer in manufacturing systems, helping to ensure consistent decision-making amidst rising complexity [9] Group 3: AI in Agriculture - In agriculture, COFCO's smart farming initiatives address systemic risks by transforming traditional practices into a continuously monitored and predictable system [10][12] - AI enables proactive risk management, shifting from reactive to preventive measures in large-scale farming operations [12] Group 4: Challenges in AI Integration - The integration of AI into industries is not merely about technological advancement but requires clear pathways for implementation [15][23] - High-complexity sectors like healthcare and education face unique challenges that necessitate tailored approaches rather than generic solutions [16][21] Group 5: Pathways to Successful AI Deployment - Huawei's ACT framework emphasizes assessing high-value scenarios, calibrating industry data, and deploying AI at scale, positioning AI as a structural variable rather than an add-on [24][25] - This cautious approach is essential in complex industries to ensure that AI is effectively embedded within existing industry logic [25] Group 6: Infrastructure and Ecosystem Development - The acceleration of industry digitalization is linked to advancements in foundational technologies such as wireless communication and data networks [27][28] - Huawei's focus on enhancing computing, networking, and storage capabilities aims to create a robust infrastructure that supports widespread AI adoption [29][30] Group 7: Bridging the Gap for SMEs - Huawei's solutions for small and medium enterprises (SMEs) aim to lower the barriers to AI adoption by providing pre-integrated, validated solutions that reduce the complexity and cost of implementation [30][31] - This approach transforms AI from a high-barrier investment into a replicable and affordable capability for various industries [31][32] Group 8: Long-term Vision for AI Integration - The transition to AI as a foundational capability requires a continuous and methodical approach, emphasizing the importance of replicable certainty in an uncertain environment [32][33] - Huawei's role in facilitating this transition reflects a broader responsibility to guide industries through the complexities of AI integration [33]

Group 1 - The National Health Commission of China is implementing eight public service initiatives to improve health services by 2025, based on public feedback [2] - All 4,845 secondary and tertiary public general hospitals in the country can now provide pediatric services, enhancing the capacity and accessibility of pediatric care [2] - 333 cities and 87 districts have established psychological and sleep clinics, with a nationwide psychological assistance hotline "12356" operational by May 1 [2][3] Group 2 - Over 200 inter-hospital test result recognition projects have been implemented across all provinces, facilitating better cooperation among medical institutions [2] - The number of childcare spots for children under three years old has reached 6.657 million, with 3.32 million being inclusive spots, and over 890,000 new inclusive spots added [2] - Starting March 31, 2025, public medical institutions will stop charging outpatient prepayment fees, and from June 30, 2025, the inpatient prepayment amount for insured patients will be reduced to the average personal payment level for the same disease [2] Group 3 - Counties with a permanent population of over 100,000 have established blood dialysis service capabilities [3] - A platform for cross-province blood fee exemption has been set up, allowing online processing of fee reductions [4] - 23 health knowledge dissemination events themed "Seasonal Solar Terms and Health" have been held to educate the public [5]

Group 1 - Linyi City is the only pilot city in the province for medical service price reform, implementing 18 price adjustments during the 14th Five-Year Plan period [2] - A total of 346 medical service project prices have been adjusted downwards, with a projected reduction of 256 million yuan in patient expenses for 2024 [2] - The price governance has included six batches of price standardization, significantly reducing costs for high-volume and high-price items, such as a 46% reduction in the price of thromboelastography tests [2] Group 2 - The new pricing policy considers the medical needs of special groups, particularly for patients requiring long-term hemodialysis, with significant price reductions implemented [3] - The new tiered pricing for hemodialysis treatment is set at 320, 280, and 240 yuan per session for tertiary, secondary, and primary hospitals respectively, eliminating additional monitoring fees [3] - The policy encourages patients to seek treatment at lower-tier hospitals, resulting in lower fees and higher reimbursement rates, thereby reducing personal financial burdens [3]

百花医药（600721）突发停牌公告：实控人正筹划股份协议转让，或致控制权易主！ 12月26日晚，百花医药公告，公司于2025年12月26日收到公司控股股东、实际控制人米在齐、米恩华、杨小玲的通知，米在齐、米恩华、杨小玲正在筹划 公司股份协议转让事宜，该事项可能导致公司控制权发生变更。 百花医药表示，鉴于本次股权协议转让事项正在洽谈当中，尚存在不确定性，根据有关规定，公司股票将于2025年12月29日(星期一)开市起停牌，预计停 牌时间不超过2个交易日。 12月26日收盘，百花医药股价报12.24元/股，涨幅达5.88%，总市值为47.07亿元。 回溯历史来看，米在齐、米恩华、杨小玲1年前通过协议转让取得公司股份。 2024年12月2日，百花医药宣布控股股东华凌工贸计划通过协议转让方式，向其实控人亦为公司实控人米在齐、米恩华和杨小玲转让其所持有的7953万股 无限售条件流通股，占公司总股本的20.71%。 同时，三位共同实控人与华凌工贸一致行动人李建城重新签署一致行动人协议。三位实控人及其一致行动人共持有公司9453万股，占总股本24.62%。 此次股份转让的价格为6.8元/股，转让总金额达到5.41亿元。转 ...